Peregrine Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-184,253	Closed	-$4.47M	–	338
2021 Q1	$4.47M	Sell	184,253 -25,658	-12%	-$622K	0.08%	256
2020 Q4	$6.73M	Buy	209,911 +18,411	+10%	+$590K	0.13%	249
2020 Q3	$5.79M	Buy	+191,500	New	+$5.79M	0.15%	211